Clinical Trials Logo

Head and Neck Neoplasm clinical trials

View clinical trials related to Head and Neck Neoplasm.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05011500 Recruiting - Clinical trials for Head and Neck Neoplasm

Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)

MASSC
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the feasibility of using open masks or no masks in combination with optical surface scanning for radiotherapy in patients with head and neck cancer.

NCT ID: NCT04477759 Recruiting - Clinical trials for Head and Neck Neoplasm

Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer

DEHART
Start date: January 26, 2021
Phase: Phase 1
Study type: Interventional

Locoregional failure remains the principal mode of mortality in head and neck squamous cell carcinoma (HNSCC) treated with conventional chemoradiation therapy. Magnetic resonance-guided radiation therapy (MRgRT) allows for adaptive radiation dose escalation based on tumor response and may improve therapeutic outcomes while limiting toxicities. This protocol evaluates a novel framework for radiation delivery with concurrent atezolizumab in patients with advanced HNSCC. Dose-Escalated Hypofractionated Adaptive Radiotherapy (DEHART) modifies radiation dose using MRgRT by escalating radiation dose to residual tumor while deescalating radiation dose to areas of tumor regression.

NCT ID: NCT04099290 Recruiting - Clinical trials for Carcinoma, Squamous Cell

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

Start date: January 14, 2020
Phase:
Study type: Observational

Circulating tumor DNA (ctDNA) is a blood-based test that measures dying or dead cancer cells that are already circulating in the blood. In this study, the investigators will enroll patients who are planning to receive surgery to remove their head and neck cancer. The investigators are interested to learn how ctDNA levels change with surgery and over the course of time. The investigators also want to determine if there are certain features of the tumor or the patient themselves that might cause ctDNA to be higher than other patients. Also, the investigators want to explore if the detection of ctDNA following surgery is related to cancer recurrence.

NCT ID: NCT03837808 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Start date: April 11, 2019
Phase: Phase 3
Study type: Interventional

This is a Phase III trial to study the effectiveness of nimotuzumab versus cisplatin combined with intensity-modulated radiation therapy (IMRT) in treating patients with stage II-III nasopharyngeal carcinoma.

NCT ID: NCT03757091 Recruiting - Clinical trials for Head and Neck Neoplasm

Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

This trial studies how well flexible intubation scope with or without video laryngoscope works in supporting endotracheal tube placement in patients with head and neck cancer before surgery. Flexible intubation scope and video laryngoscope are devices that have a small camera to help the doctor see the patient's airway on a screen. Both devices may help the doctor who gives anesthesia prevent complications from placing the breathing tube (such as pain or mouth injury).